Associate Professor Jennifer Maynard, the Laurence E. McMakin, Jr. Centennial Faculty Fellow, has teamed up with biotech company Synthetic Biologics, Inc. to develop a monoclonal antibody (mAb) therapy for the treatment of pertussis, commonly known as whooping cough.

Whooping cough causes an estimated 294,000 deaths annually worldwide, primarily among young, unvaccinated children.  Recent reports … Read the rest »